Provided by Tiger Trade Technology Pte. Ltd.

Perpetuals.com Ltd

3.34
+0.03000.91%
Post-market: 3.400.0600+1.80%19:30 EDT
Volume:16.77K
Turnover:55.36K
Market Cap:27.10M
PE:-0.67
High:3.60
Open:3.33
Low:3.20
Close:3.31
52wk High:8.83
52wk Low:2.42
Shares:8.11M
Float Shares:5.45M
Volume Ratio:0.30
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.9964
EPS(LYR):-0.7902
ROE:-72.52%
ROA:-8.93%
PB:1.14
PE(LYR):-4.23

Loading ...

Perpetuals.com Ends Talks to Buy AI Financial Unit Alt5 Sigma Canada

Reuters
·
Jul 14

Perpetuals.com - Perpetuals Terminates Letter of Intent to Buy Alt5 Sigma Canada

THOMSON REUTERS
·
Jul 14

Statement on Terminating the Letter of Intent with AI Financial Corporation

THOMSON REUTERS
·
Jul 14

Perpetuals.com Ltd: Has Decided not to Further Pursue Acquisition of AI Financial Corporation's Subsidiary Alt5 Sigma Canada, Inc.

THOMSON REUTERS
·
Jul 14

Adrs Close Lower; Perpetuals.com Ltd. Declines 16%

Dow Jones
·
Jul 14

NASDAQ Trade Halt Volatility Trading Pause at 12:05 Pm

Reuters
·
Jul 14

Adrs Advance; Huize Holding Ltd. Climbs 17%

Dow Jones
·
Jul 11

Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors

GlobeNewswire
·
Jul 08

Perpetuals.com ‘currently conducting’ due diligence on AI Financial acquisition

TIPRANKS
·
Jul 07

Perpetuals.com - Perpetuals Signs Non-binding Term Sheet to Explore Acquisition of Alt5 Sigma Canada

THOMSON REUTERS
·
Jul 07

Statement on a Proposed Transaction with AI Financial Corporation

THOMSON REUTERS
·
Jul 07

Perpetuals.com Shareholders Approve Stated Capital Reduction at Extraordinary Meeting

Reuters
·
Jul 07

Perpetuals.com Announces Ordinary General Meeting of Shareholders

Reuters
·
Jul 02

Perpetuals.com signs exchange agreement with Datavault AI to list tokenized commodities

Reuters
·
Jun 03

Perpetuals.com announces agreement with Datavault AI to list tokenized assets

TIPRANKS
·
Jun 02

Perpetuals reports $4.5 billion UpsideOnly trading volume in first two weeks

Reuters
·
Jun 02

Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting

GlobeNewswire
·
Jun 01

Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026

GlobeNewswire
·
Jun 01

Perpetuals.com CEO Patrick Gruhn to present at Emerging Growth Conference

Reuters
·
May 28

Oncopeptides to spotlight Pepaxti data and PDC strategy at EHA 2026

TIPRANKS
·
May 27